With just few days of treatment, the patient started responding well and finally complete clinical resolution of infection was attained
India is contributing 13% to the global asthma burden and a disproportionate 43% of the global asthma deaths.
Arun is currently working as Vice President (Strategy) in Solara leading Business finance & Strategy function
The plan is to set up an ultramodern Solvent Recovery Plant for third party purposes
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
PLI scheme envisages manufacturing of 41 Bulk Drugs with a total outlay of Rs. 6,940 cr. during the tenure of the scheme from 2020-21 to 2029-30
The U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergies
VELSIPITY is the first and only oral advanced ulcerative colitis therapy approved for use in patients 16 years of age or older in the EU
Adjuvants are components of vaccines that help to enhance the magnitude, breadth, and duration of the immune response to vaccination
The company is strongly committed to enhancing customer satisfaction and catering to the discerning needs of renowned pharmaceutical companies
Subscribe To Our Newsletter & Stay Updated
